US FDA's drug division chief resigns amid ethics concerns and lawsuit

The director of the U.S. Food and Drug Administration's Center for Drug Evaluation and Research, George Tidmarsh, resigned on ...

Dr. Oz and FDA chief say biosimilar drug reform will lower prices

Trump administration officials pledged Monday that major reforms for biosimilar drug approvals will expand access and lower ...

FDA announces plan to slash ‘sky-high’ drug costs and save Americans money

The FDA said it proposed significant changes to simplify biosimilarity studies and reduce what it described as unnecessary ...

FDA’s top drug regulator sued by drug company, resigns amid conduct probe

The top drug regulator at the Food and Drug Administration (FDA) resigned Sunday, according to officials, after being accused ...

FDA flags cholesterol drug for possible effectiveness issues

The Food and Drug Administration has initiated a Class II recall of 141,984 bottles of atorvastatin calcium after tests ...
KTBS 3

Top FDA Drug Chief Resigns While Under Investigation

Dr. George Tidmarsh, who joined the FDA in July, stepped down Sunday, The New York Times reported. His resignation came just ...

Sydnexis unveils more data for SYD-101 days after FDA refusal

The FDA issued Sydnexis with a complete response letter on 23 October, blocking SYD-101 from entering the US market.

FDA’s top drug regulator resigns after federal officials probe ‘serious concerns’ about his conduct

Dr. George Tidmarsh had been placed on leave Friday after Health and Human Services officials were notified of the issues, a ...
STAT

Experts worry FDA’s credibility is being shredded by scandal and ‘soap opera’

It was the latest shockwave to sweep through an agency beset by all kinds of tumult in recent months. In interviews, ...
STAT

Lawsuit against top FDA drug regulator is packed with incendiary texts, emails

A lawsuit filed against George Tidmarsh, who resigned from a top FDA post on Sunday, includes a series of incendiary texts ...